Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.70 is 42% below its 5-year average of 8.09, near the low end of its 5-year range (4.70–19.97).
As of the fiscal period ended Tuesday, June 30, 2026. 55.97% below its 12-month average of 10.68.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.70.
CURRENT RATIO
4.70
CURRENT RATIO AVG TTM
10.68
CURRENT RATIO AVG 3Y
9.42
CURRENT RATIO AVG 5Y
8.09
CURRENT RATIO AVG 10Y
5.10
CURRENT RATIO AVG 15Y
6.04
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-55.97%
CURRENT VS 3Y AVG
-50.10%
CURRENT VS 5Y AVG
-41.91%
CURRENT VS 10Y AVG
-7.88%
CURRENT VS 15Y AVG
-22.14%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+25.03%
vs the sector median at left
Market Cap
$5.21M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
Market Cap
$5.24M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
Market Cap
$5.32M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.35M
Current Ratio
10.60
TTM Avg
4.75
3Y Avg
13.42
5Y Avg
23.90
Market Cap
$4.97M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.22M | 4.70 | 10.68 | 9.42 | 8.09 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | 1.88 | 1.74 | 1.99 | 1.99 |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 3.01 | 3.95 | 2.52 | 4.28 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | 1.44 | 1.10 | 1.11 | 1.95 |
| Soligenix, Inc. (SNGX)vs › | $5.31M | 2.77 | 2.10 | 1.65 | 2.34 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | 0.09 | 0.18 | 0.44 | 0.97 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | 0.19 | 0.06 | 0.46 | 2.58 |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | 10.60 | 4.75 | 13.42 | 23.90 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | 1.12 | 0.07 | 0.07 | 0.12 |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | 7.43 | 7.85 | 10.06 | 11.10 |
Current Ratio
4.70
Quick Ratio
4.70
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.70 |
| 2026-03-31 | 4.96 |
| 2025-12-31 | 12.55 |
| 2025-09-30 | 19.97 |
| 2025-06-30 | 11.21 |
| 2025-03-31 | 8.90 |
| 2024-12-31 | 10.68 |
| 2024-09-30 | 19.40 |
| 2024-06-30 | 6.33 |
| 2024-03-31 | 5.59 |
| 2023-12-31 | 5.33 |
| 2023-09-30 | 5.24 |
| 2023-06-30 | 7.61 |
| 2023-03-31 | 6.93 |
| 2022-12-31 | 7.60 |
| 2022-09-30 | 6.84 |
| 2022-06-30 | 8.19 |
| 2022-03-31 | 9.41 |
| 2021-12-31 | 12.33 |
| 2021-09-30 | 10.61 |
| 2021-06-30 | 8.74 |
| 2021-03-31 | 9.10 |
| 2020-12-31 | 3.94 |
| 2020-09-30 | 3.51 |
| 2020-06-30 | 1.99 |
| 2020-03-31 | 1.51 |
| 2019-12-31 | 1.83 |
| 2019-09-30 | 2.46 |
| 2019-06-30 | 2.58 |
| 2019-03-31 | 0.89 |
| 2018-12-31 | 1.14 |
| 2018-09-30 | 1.29 |
| 2018-06-30 | 2.37 |
| 2018-03-31 | 0.33 |
| 2017-12-31 | 0.73 |
| 2017-09-30 | 1.16 |
| 2017-06-30 | 1.99 |
| 2017-03-31 | 2.53 |
| 2016-12-31 | 1.02 |
| 2016-09-30 | 2.03 |
| 2016-06-30 | 2.87 |
| 2016-03-31 | 3.93 |
| 2015-12-31 | 5.68 |
| 2015-09-30 | 9.44 |
| 2015-06-30 | 19.61 |
| 2015-03-31 | 16.57 |
| 2014-12-31 | 20.47 |
| 2014-09-30 | 22.90 |
| 2014-06-30 | 26.63 |
| 2014-03-31 | 16.45 |
| 2013-12-31 | 0.14 |
| 2013-09-30 | 0.22 |
| 2013-06-30 | 0.17 |
| 2013-03-31 | 0.99 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
